Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Arformoterol Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Brovana
  • 1.4.3 Generic
• 1.5 Market by Application
  • 1.5.1 Global Arformoterol Market Share by Application (2014-2025)
  • 1.5.2 Hospital
  • 1.5.3 Drug store
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Arformoterol Market Size
• 2.2 Arformoterol Growth Trends by Regions
  • 2.2.1 Arformoterol Market Size by Regions (2014-2025)
  • 2.2.2 Arformoterol Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Opportunities

3 Market Share by Key Players

• 3.1 Arformoterol Market Size by Manufacturers
  • 3.1.1 Global Arformoterol Revenue by Manufacturers (2014-2019)
  • 3.1.2 Global Arformoterol Revenue Market Share by Manufacturers (2014-2019)
  • 3.1.3 Global Arformoterol Market Concentration Ratio (CR5 and HHI)
• 3.2 Arformoterol Key Players Head office and Area Served
• 3.3 Key Players Arformoterol Product/Solution/Service
• 3.4 Date of Enter into Arformoterol Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Arformoterol Market Size by Type (2014-2019)
• 4.2 Global Arformoterol Market Size by Application (2014-2019)

5 United States

• 5.1 United States Arformoterol Market Size (2014-2019)
• 5.2 Arformoterol Key Players in United States
• 5.3 United States Arformoterol Market Size by Type
• 5.4 United States Arformoterol Market Size by Application

6 Europe

• 6.1 Europe Arformoterol Market Size (2014-2019)
• 6.2 Arformoterol Key Players in Europe
• 6.3 Europe Arformoterol Market Size by Type
• 6.4 Europe Arformoterol Market Size by Application

7 China

• 7.1 China Arformoterol Market Size (2014-2019)
• 7.2 Arformoterol Key Players in China
• 7.3 China Arformoterol Market Size by Type
• 7.4 China Arformoterol Market Size by Application

8 Japan

• 8.1 Japan Arformoterol Market Size (2014-2019)
• 8.2 Arformoterol Key Players in Japan
• 8.3 Japan Arformoterol Market Size by Type
• 8.4 Japan Arformoterol Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Arformoterol Market Size (2014-2019)
• 9.2 Arformoterol Key Players in Southeast Asia
• 9.3 Southeast Asia Arformoterol Market Size by Type
• 9.4 Southeast Asia Arformoterol Market Size by Application

10 India

• 10.1 India Arformoterol Market Size (2014-2019)
• 10.2 Arformoterol Key Players in India
• 10.3 India Arformoterol Market Size by Type
• 10.4 India Arformoterol Market Size by Application

11 Central & South America

• 11.1 Central & South America Arformoterol Market Size (2014-2019)
• 11.2 Arformoterol Key Players in Central & South America
• 11.3 Central & South America Arformoterol Market Size by Type
• 11.4 Central & South America Arformoterol Market Size by Application

12 International Players Profiles

• 12.1 Sunovion Pharmaceuticals
  • 12.1.1 Sunovion Pharmaceuticals Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Arformoterol Introduction
  • 12.1.4 Sunovion Pharmaceuticals Revenue in Arformoterol Business (2014-2019)
  • 12.1.5 Sunovion Pharmaceuticals Recent Development
• 12.2 Cipla
  • 12.2.1 Cipla Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Arformoterol Introduction
  • 12.2.4 Cipla Revenue in Arformoterol Business (2014-2019)
  • 12.2.5 Cipla Recent Development

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer

Arformoterol is a long-acting β2 adrenoreceptor agonist (LABA) indicated for the treatment of chronic obstructive pulmonary disease (COPD). It is sold by Sunovion, under the trade name Brovana, as a solution of arformoterol tartrate to be administered twice daily (morning and evening) by nebulization.
In 2018, the global Arformoterol market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Arformoterol status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Arformoterol development in United States, Europe and China.

The key players covered in this study
Sunovion Pharmaceuticals
Cipla
...

Market segment by Type, the product can be split into
Brovana
Generic

Market segment by Application, split into
Hospital
Drug store

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Arformoterol status, future forecast, growth opportunity, key market and key players.
To present the Arformoterol development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Arformoterol are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.